Primary Clinical Endpoint of 12-Month Binary MACCE. 12 months post enrollment [clinicaltrials_resource:338d30aa2d6ccfeb957a2815c04024b6]
Number of participants at primary clinical endpoint of 12-Month binary MACCE. MACCE is defined as: all cause death, cerebrovascular event (stroke), cocumented myocardial infarction, repeat revascularization (PCI and/or CABG).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Primary Clinical Endpoint of 12-Month Binary MACCE. 12 months post enrollment [clinicaltrials_resource:338d30aa2d6ccfeb957a2815c04024b6]
Number of participants at primary clinical endpoint of 12-Month binary MACCE. MACCE is defined as: all cause death, cerebrovascular event (stroke), cocumented myocardial infarction, repeat revascularization (PCI and/or CABG).
Bio2RDF identifier
338d30aa2d6ccfeb957a2815c04024b6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:338d30aa2d6ccfeb957a2815c04024b6
measure [clinicaltrials_vocabulary:measure]
Primary Clinical Endpoint of 12-Month Binary MACCE.
time frame [clinicaltrials_vocabulary:time-frame]
12 months post enrollment
description
Number of participants at prim ...... ularization (PCI and/or CABG).
identifier
clinicaltrials_resource:338d30aa2d6ccfeb957a2815c04024b6
title
Primary Clinical Endpoint of 12-Month Binary MACCE. 12 months post enrollment
@en
type
label
Primary Clinical Endpoint of 1 ...... d30aa2d6ccfeb957a2815c04024b6]
@en